# MediSafe Project

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medisafe-project

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.medisafe.com
- Total disclosed funding: $51M
- Latest round: Series C (Feb 25, 2021)
- Investors on record: 14

## About

Based in the US, MediSafe Project Ltd is a digital health company specializing in medication adherence solutions, enhancing patient engagement through innovative technology and dedicated support for healthcare providers and patients alike.MediSafe Project Ltd, founded in 2012 in Boston, US, focuses on providing digital health solutions to improve medication adherence. The company has raised a total of USD 30.00 mn, primarily through its latest funding round, Series C, which took place on February 25, 2021, attracting investors such as Alive Healthcare Partners and Sanofi Ventures. The founders, Omri Shor and Vincent Thillerot, have a history in the healthcare technology space, contributing to the company's strategic direction.MediSafe delivers a suite of digital health solutions focused on enhancing medication adherence and persistence through advanced technology. The core offerings include Medisafe, a medication management platform designed to optimize patient engagement, and the Pathways tool, aiding healthcare providers in managing patient care, particularly for FDA-approved monoclonal antibodies for Alzheimer's disease. MediSafe's Voice Intelligent Agent (VIA) is an AI-driven voice assistant that streamlines patient interaction and retention for specialty brands, serving healthcare providers, clinics, infusion centers, caregivers, and patients across the U.S. and international markets.MediSafe operates on a business-to-business (B2B) model, forging partnerships with pharmaceutical companies, healthcare providers, and wellness organizations. Its revenue primarily comes from subscription fees for access to its digital platforms and potential transaction-based agreements tied to patient engagement outcomes. The flagship products play a crucial role in revenue generation, allowing clients to leverage MediSafe's technology to enhance patient adherence and outcomes as the company prepares to meet upcoming FDA regulations.Following its Series C funding of USD 30.00 mn in February 2021, MediSafe plans to utilize the new capital to expand its end-to-end solutions for patients managing medications and accelerate revenue growth. The company is set to launch additional products that enhance medication management capabilities and is actively targeting expansion into new geographic regions by 2023, strengthening its presence in international markets. This strategic initiative aligns with MediSafe's commitment to addressing industry needs and regulatory guidelines.

## Funding rounds

- Series C, Feb 25, 2021, $30M — Pitango, Consensus Business Group, Qualcomm Ventures, M Ventures, Menora Mivtachim Group, Leumi Partners, Sanofi Ventures, lool ventures, 7wireVentures, Triventures, OurCrowd, Octopus Investments, ALIVE
- Series B, Mar 1, 2017, $15M — Pitango, Qualcomm Ventures, M Ventures, lool ventures, 7wireVentures, Triventures, Octopus Investments
- Series A, Jan 13, 2015, $6M — Pitango, lool ventures, 7wireVentures, Triventures
- Seed, May 15, 2012 — M12

## Investors

- M12 (https://capitalatlas.ai/funds/m12) — Seed
- Pitango (https://capitalatlas.ai/funds/pitango) — Series A, Series B, Series C
- lool ventures (https://capitalatlas.ai/funds/lool-ventures) — Series A, Series B, Series C
- 7wireVentures (https://capitalatlas.ai/funds/7wireventures) — Series A, Series B, Series C
- Triventures (https://capitalatlas.ai/funds/triventures) — Series A, Series B, Series C
- Qualcomm Ventures (https://capitalatlas.ai/funds/qualcomm-ventures) — Series B, Series C
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series B, Series C
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series B, Series C
- Consensus Business Group — Series C
- Menora Mivtachim Group — Series C
- Leumi Partners — Series C
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series C
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series C
- ALIVE — Series C